Vista Pharmaceuticals shareholding pattern

VISTAPH

7

0.08 (-1.13%)
Last updated on 1 Feb, 2026 | 15:25 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Vista Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

21.19%

Mutual Fund

0.02%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

78.79%

Others

0%

Total Promoters
MAR '25
21.19%
JUN '25
21.19%
SEP '25
21.19%
DEC '25
21.19%

Summary

For Year 2025-26, Vista Pharmaceuticals reports the following shareholding: Total Promoters at 21.19%, Mutual Fund at 0.02%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 78.79%. This breakdown provides a quick snapshot of ownership distribution for Vista Pharmaceuticals in 2025-26.

Vista Pharmaceuticals FAQs

As of 02-2026, the promoter shareholding in Vista Pharmaceuticals stands at 21.19% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Vista Pharmaceuticals is 0% and 0% respectively.

The retail shareholding of the Vista Pharmaceuticals is 78.79%.

Changes in shareholding patterns of Vista Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Vista Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.